home > drugs a-z list > m-r-vax (measles and rubella virus vaccine live) drug center

M-R-Vax

font size

M-R-Vax II Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

M-R-Vax II Prescribing Information: Indications & Dosage

M-R-VAX (measles and rubella virus vaccine live) II is indicated for simultaneous immunization against measles and rubella in persons 15 months of age or older. A second dose of M-R-VAX (measles and rubella virus vaccine live) II or monovalent measles vaccine is recommended (see Revaccination  ).

Infants who are less than 15 months of age may fail to respond to the measles component of the vaccine due to presence in the circulation of residual measles antibody of maternal origin; the younger the infant, the lower the likelihood of seroconversion. In geographically is...

Read the complete drug monograph for M-R-Vax II »

What is M-R-Vax II Prescribing Information?

Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More

Related Resources for M-R-Vax II

© M-R-Vax II Patient Information is supplied by Cerner Multum, Inc. and M-R-Vax II Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Additional M-R-Vax Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Privacy Policy

Parenting and Pregnancy

Get tips for baby and you.


From WebMD

Parenting Resources
Featured Centers
Health Solutions From Our Sponsors